The role of survivin and raf-1 kinase against enhancement of pancreatic beta-cell apoptosis in patients with type 2 diabetes mellitus

E. V.A. Decroli, Asman Manaf, Syafril Syahbuddin, Sarwono Waspadji, Dwisari Dillasamola

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: This study aimed to reveal differences in levels of survivin and Raf-1 kinase in prediabetes, controlled Type 2 diabetes mellitus (T2DM), uncontrolled T2DM, and their relationship with hemoglobin A1c (HbA1c) levels and serum triglyceride levels. Methods: This study was an observational study with a cross-sectional design. The study involved 60 people with T2DM who visited the endocrine and metabolic clinic and 30 prediabetes patients. The variables were survivin levels and Raf-1 kinase enzymes that examined using enzyme-linked immunosorbent assay techniques. HbA1c values are measured by high-performance liquid chromatography and triglyceride levels measured by enzymatic method. Results: Average levels of Raf-1 kinase were significantly higher in the prediabetes group, controlled T2DM, and uncontrolled T2DM (11.6±1.4 pg mL, 9.9±1.1 pg/mL, and 9.1±1.5 pg/mL). Survivin was significantly higher in the prediabetes group, controlled T2DM, and uncontrolled T2DM (5.4±0.4 pg mL, 5.0±0.2 pg/mL, and 4.7±0.1 pg/mL). There was no correlation between HbA1c with Raf-1 kinase levels (R=−0.215, p=0.250), but there was a correlation between HbA1c with serum survivin levels (R=−0.6, *p<0.05). There was a correlation between the levels of triglycerides with survivin but not with Raf-1 kinase (R=−0.267, *p=0.039). Conclusion: Survivin and Raf-1 kinase levels are lower in uncontrolled T2DM. This explained the role of survivin and Raf-1 kinase against enhancement of pancreatic beta-cell apoptosis in patients with T2DM.

Original languageEnglish
Pages (from-to)344-347
Number of pages4
JournalAsian Journal of Pharmaceutical and Clinical Research
Volume11
Issue number11
DOIs
Publication statusPublished - 1 Jan 2018

Fingerprint

Proto-Oncogene Proteins c-raf
Insulin-Secreting Cells
Type 2 Diabetes Mellitus
Apoptosis
Prediabetic State
Hemoglobins
Triglycerides
Immunosorbent Techniques
Serum
Observational Studies
Enzyme-Linked Immunosorbent Assay
High Pressure Liquid Chromatography

Keywords

  • Hemoglobin A1c
  • Raf-1 kinase
  • Survivin
  • Type 2 diabetes mellitus

Cite this

@article{d1561bed75674cf086db1bc4da0364e9,
title = "The role of survivin and raf-1 kinase against enhancement of pancreatic beta-cell apoptosis in patients with type 2 diabetes mellitus",
abstract = "Objective: This study aimed to reveal differences in levels of survivin and Raf-1 kinase in prediabetes, controlled Type 2 diabetes mellitus (T2DM), uncontrolled T2DM, and their relationship with hemoglobin A1c (HbA1c) levels and serum triglyceride levels. Methods: This study was an observational study with a cross-sectional design. The study involved 60 people with T2DM who visited the endocrine and metabolic clinic and 30 prediabetes patients. The variables were survivin levels and Raf-1 kinase enzymes that examined using enzyme-linked immunosorbent assay techniques. HbA1c values are measured by high-performance liquid chromatography and triglyceride levels measured by enzymatic method. Results: Average levels of Raf-1 kinase were significantly higher in the prediabetes group, controlled T2DM, and uncontrolled T2DM (11.6±1.4 pg mL, 9.9±1.1 pg/mL, and 9.1±1.5 pg/mL). Survivin was significantly higher in the prediabetes group, controlled T2DM, and uncontrolled T2DM (5.4±0.4 pg mL, 5.0±0.2 pg/mL, and 4.7±0.1 pg/mL). There was no correlation between HbA1c with Raf-1 kinase levels (R=−0.215, p=0.250), but there was a correlation between HbA1c with serum survivin levels (R=−0.6, *p<0.05). There was a correlation between the levels of triglycerides with survivin but not with Raf-1 kinase (R=−0.267, *p=0.039). Conclusion: Survivin and Raf-1 kinase levels are lower in uncontrolled T2DM. This explained the role of survivin and Raf-1 kinase against enhancement of pancreatic beta-cell apoptosis in patients with T2DM.",
keywords = "Hemoglobin A1c, Raf-1 kinase, Survivin, Type 2 diabetes mellitus",
author = "Decroli, {E. V.A.} and Asman Manaf and Syafril Syahbuddin and Sarwono Waspadji and Dwisari Dillasamola",
year = "2018",
month = "1",
day = "1",
doi = "10.22159/ajpcr.2018.v11i11.27671",
language = "English",
volume = "11",
pages = "344--347",
journal = "Asian Journal of Pharmaceutical and Clinical Research",
issn = "0974-2441",
publisher = "Asian Journal of Pharmaceutical and Clinical Research",
number = "11",

}

The role of survivin and raf-1 kinase against enhancement of pancreatic beta-cell apoptosis in patients with type 2 diabetes mellitus. / Decroli, E. V.A.; Manaf, Asman; Syahbuddin, Syafril; Waspadji, Sarwono; Dillasamola, Dwisari.

In: Asian Journal of Pharmaceutical and Clinical Research, Vol. 11, No. 11, 01.01.2018, p. 344-347.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The role of survivin and raf-1 kinase against enhancement of pancreatic beta-cell apoptosis in patients with type 2 diabetes mellitus

AU - Decroli, E. V.A.

AU - Manaf, Asman

AU - Syahbuddin, Syafril

AU - Waspadji, Sarwono

AU - Dillasamola, Dwisari

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objective: This study aimed to reveal differences in levels of survivin and Raf-1 kinase in prediabetes, controlled Type 2 diabetes mellitus (T2DM), uncontrolled T2DM, and their relationship with hemoglobin A1c (HbA1c) levels and serum triglyceride levels. Methods: This study was an observational study with a cross-sectional design. The study involved 60 people with T2DM who visited the endocrine and metabolic clinic and 30 prediabetes patients. The variables were survivin levels and Raf-1 kinase enzymes that examined using enzyme-linked immunosorbent assay techniques. HbA1c values are measured by high-performance liquid chromatography and triglyceride levels measured by enzymatic method. Results: Average levels of Raf-1 kinase were significantly higher in the prediabetes group, controlled T2DM, and uncontrolled T2DM (11.6±1.4 pg mL, 9.9±1.1 pg/mL, and 9.1±1.5 pg/mL). Survivin was significantly higher in the prediabetes group, controlled T2DM, and uncontrolled T2DM (5.4±0.4 pg mL, 5.0±0.2 pg/mL, and 4.7±0.1 pg/mL). There was no correlation between HbA1c with Raf-1 kinase levels (R=−0.215, p=0.250), but there was a correlation between HbA1c with serum survivin levels (R=−0.6, *p<0.05). There was a correlation between the levels of triglycerides with survivin but not with Raf-1 kinase (R=−0.267, *p=0.039). Conclusion: Survivin and Raf-1 kinase levels are lower in uncontrolled T2DM. This explained the role of survivin and Raf-1 kinase against enhancement of pancreatic beta-cell apoptosis in patients with T2DM.

AB - Objective: This study aimed to reveal differences in levels of survivin and Raf-1 kinase in prediabetes, controlled Type 2 diabetes mellitus (T2DM), uncontrolled T2DM, and their relationship with hemoglobin A1c (HbA1c) levels and serum triglyceride levels. Methods: This study was an observational study with a cross-sectional design. The study involved 60 people with T2DM who visited the endocrine and metabolic clinic and 30 prediabetes patients. The variables were survivin levels and Raf-1 kinase enzymes that examined using enzyme-linked immunosorbent assay techniques. HbA1c values are measured by high-performance liquid chromatography and triglyceride levels measured by enzymatic method. Results: Average levels of Raf-1 kinase were significantly higher in the prediabetes group, controlled T2DM, and uncontrolled T2DM (11.6±1.4 pg mL, 9.9±1.1 pg/mL, and 9.1±1.5 pg/mL). Survivin was significantly higher in the prediabetes group, controlled T2DM, and uncontrolled T2DM (5.4±0.4 pg mL, 5.0±0.2 pg/mL, and 4.7±0.1 pg/mL). There was no correlation between HbA1c with Raf-1 kinase levels (R=−0.215, p=0.250), but there was a correlation between HbA1c with serum survivin levels (R=−0.6, *p<0.05). There was a correlation between the levels of triglycerides with survivin but not with Raf-1 kinase (R=−0.267, *p=0.039). Conclusion: Survivin and Raf-1 kinase levels are lower in uncontrolled T2DM. This explained the role of survivin and Raf-1 kinase against enhancement of pancreatic beta-cell apoptosis in patients with T2DM.

KW - Hemoglobin A1c

KW - Raf-1 kinase

KW - Survivin

KW - Type 2 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=85056584770&partnerID=8YFLogxK

U2 - 10.22159/ajpcr.2018.v11i11.27671

DO - 10.22159/ajpcr.2018.v11i11.27671

M3 - Article

AN - SCOPUS:85056584770

VL - 11

SP - 344

EP - 347

JO - Asian Journal of Pharmaceutical and Clinical Research

JF - Asian Journal of Pharmaceutical and Clinical Research

SN - 0974-2441

IS - 11

ER -